<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00881985</url>
  </required_header>
  <id_info>
    <org_study_id>UW 09-051</org_study_id>
    <nct_id>NCT00881985</nct_id>
  </id_info>
  <brief_title>Effect of Continuous Positive Airway Pressure for Treatment of Obstructive Sleep Apnea on Resistant Hypertension</brief_title>
  <official_title>Effect of Continuous Positive Airway Pressure for Treatment of Obstructive Sleep Apnea on Drug-resistant Hypertension : A Randomized Controlled Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>The University of Hong Kong</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>The University of Hong Kong</source>
  <brief_summary>
    <textblock>
      The objectives of this study are to investigate the effect of continuous positive airway
      pressure (CPAP) treatment on blood pressure control and vascular inflammation in subjects
      with resistant hypertension and moderate obstructive sleep apnea (OSA).
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Resistant hypertension is defined as blood pressure that remains above goal in spite of
      concurrent use of 3 antihypertensive agents of different classes. Resistant hypertension is
      defined in order to identify patients who are at risk of having secondary causes of
      hypertension, and who may benefit from specific diagnostic and therapeutic applications.
      Despite the fact that OSA is listed as one of the causes of resistant HT , paucity of works
      has demonstrated the magnitude of problems of untreated OSA in subjects with resistant HT.
      There is so far two study demonstrating the beneficial effect of CPAP treatment in subjects
      with resistant HT, though both studies were flawed by not including the control group, no
      randomization and limited sample size. We aim at conducting a randomized controlled study to
      explore the beneficial effect of CPAP treatment in subjects with OSA and resistant
      hypertension.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>March 2009</start_date>
  <completion_date type="Anticipated">December 2018</completion_date>
  <primary_completion_date type="Anticipated">December 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>mean systolic blood pressure</measure>
    <time_frame>8 weeks</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>mean arterial blood pressure</measure>
    <time_frame>8 weeks</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>mean diastolic blood pressure</measure>
    <time_frame>8 weeks</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>high sensitivity C-reactive protein</measure>
    <time_frame>8 weeks</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>cardiac injury marker</measure>
    <time_frame>8 weeks</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>oxidative stress marker</measure>
    <time_frame>8 weeks</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">64</enrollment>
  <condition>Resistant Hypertension</condition>
  <condition>Obstructive Sleep Apnea</condition>
  <arm_group>
    <arm_group_label>continuous positive airway pressure</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>observation</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>continuous positive airway pressure</intervention_name>
    <description>Use CPAP whenever sleep</description>
    <arm_group_label>continuous positive airway pressure</arm_group_label>
    <other_name>CPAP</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Age 18 - 65

          -  known hypertension on ≧ 3 anti-hypertensive drugs

          -  Apnea-hypopnea index ≧15

          -  able to give informed written consent

        Exclusion Criteria:

          -  moderate renal impairment (glomerular filtration rate &lt;30 mL/min/m2 )

          -  endocrine/renal/cardiac causes of secondary HT

          -  congestive heart failure and clinically fluid overloaded

          -  On drugs that elevates BP e.g. NSAID, steroid

          -  Non-compliance to anti-hypertensive medications

          -  Unstable medical conditions such as unstable angina, recent myocardial
             infarction/stroke within 3 months

          -  Active inflammatory/infective conditions e.g. rheumatoid arthritis

          -  Excessive sleepiness that can be risky e.g. occupational driver, machine operator

          -  Modification/changes of anti-hypertensive regimen within 8 weeks
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Mary SM Ip, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>The University of Hong Kong</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Mary SM Ip, MD</last_name>
    <phone>852-28554455</phone>
    <email>msmip@hkucc.hku.hk</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Macy MS Lui, MRCP</last_name>
    <phone>852-28553312</phone>
    <email>macylui@graduate.hku.hk</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Queen Mary Hospital</name>
      <address>
        <city>Hong Kong</city>
        <zip>852</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Mary SM Ip, MD</last_name>
      <phone>852-28554455</phone>
      <email>msmip@hkucc.hku.hk</email>
    </contact>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <reference>
    <citation>Nieto FJ, Young TB, Lind BK, Shahar E, Samet JM, Redline S, D'Agostino RB, Newman AB, Lebowitz MD, Pickering TG. Association of sleep-disordered breathing, sleep apnea, and hypertension in a large community-based study. Sleep Heart Health Study. JAMA. 2000 Apr 12;283(14):1829-36. Erratum in: JAMA 2002 Oct 23-30;288(16):1985.</citation>
    <PMID>10770144</PMID>
  </reference>
  <reference>
    <citation>Young T, Peppard P, Palta M, Hla KM, Finn L, Morgan B, Skatrud J. Population-based study of sleep-disordered breathing as a risk factor for hypertension. Arch Intern Med. 1997 Aug 11-25;157(15):1746-52.</citation>
    <PMID>9250236</PMID>
  </reference>
  <reference>
    <citation>Pepperell JC, Ramdassingh-Dow S, Crosthwaite N, Mullins R, Jenkinson C, Stradling JR, Davies RJ. Ambulatory blood pressure after therapeutic and subtherapeutic nasal continuous positive airway pressure for obstructive sleep apnoea: a randomised parallel trial. Lancet. 2002 Jan 19;359(9302):204-10.</citation>
    <PMID>11812555</PMID>
  </reference>
  <reference>
    <citation>Becker HF, Jerrentrup A, Ploch T, Grote L, Penzel T, Sullivan CE, Peter JH. Effect of nasal continuous positive airway pressure treatment on blood pressure in patients with obstructive sleep apnea. Circulation. 2003 Jan 7;107(1):68-73.</citation>
    <PMID>12515745</PMID>
  </reference>
  <reference>
    <citation>Norman D, Loredo JS, Nelesen RA, Ancoli-Israel S, Mills PJ, Ziegler MG, Dimsdale JE. Effects of continuous positive airway pressure versus supplemental oxygen on 24-hour ambulatory blood pressure. Hypertension. 2006 May;47(5):840-5. Epub 2006 Apr 3.</citation>
    <PMID>16585412</PMID>
  </reference>
  <reference>
    <citation>Calhoun DA, Jones D, Textor S, Goff DC, Murphy TP, Toto RD, White A, Cushman WC, White W, Sica D, Ferdinand K, Giles TD, Falkner B, Carey RM. Resistant hypertension: diagnosis, evaluation, and treatment. A scientific statement from the American Heart Association Professional Education Committee of the Council for High Blood Pressure Research. Hypertension. 2008 Jun;51(6):1403-19. doi: 10.1161/HYPERTENSIONAHA.108.189141. Epub 2008 Apr 7.</citation>
    <PMID>18391085</PMID>
  </reference>
  <reference>
    <citation>Logan AG, Perlikowski SM, Mente A, Tisler A, Tkacova R, Niroumand M, Leung RS, Bradley TD. High prevalence of unrecognized sleep apnoea in drug-resistant hypertension. J Hypertens. 2001 Dec;19(12):2271-7.</citation>
    <PMID>11725173</PMID>
  </reference>
  <reference>
    <citation>Grote L, Hedner J, Peter JH. Sleep-related breathing disorder is an independent risk factor for uncontrolled hypertension. J Hypertens. 2000 Jun;18(6):679-85.</citation>
    <PMID>10872551</PMID>
  </reference>
  <reference>
    <citation>Lavie P, Hoffstein V. Sleep apnea syndrome: a possible contributing factor to resistant. Sleep. 2001 Sep 15;24(6):721-5.</citation>
    <PMID>11560187</PMID>
  </reference>
  <reference>
    <citation>Logan AG, Tkacova R, Perlikowski SM, Leung RS, Tisler A, Floras JS, Bradley TD. Refractory hypertension and sleep apnoea: effect of CPAP on blood pressure and baroreflex. Eur Respir J. 2003 Feb;21(2):241-7.</citation>
    <PMID>12608436</PMID>
  </reference>
  <reference>
    <citation>Martínez-García MA, Gómez-Aldaraví R, Soler-Cataluña JJ, Martínez TG, Bernácer-Alpera B, Román-Sánchez P. Positive effect of CPAP treatment on the control of difficult-to-treat hypertension. Eur Respir J. 2007 May;29(5):951-7. Epub 2007 Feb 14.</citation>
    <PMID>17301092</PMID>
  </reference>
  <verification_date>May 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>April 14, 2009</study_first_submitted>
  <study_first_submitted_qc>April 15, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">April 16, 2009</study_first_posted>
  <last_update_submitted>May 18, 2018</last_update_submitted>
  <last_update_submitted_qc>May 18, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">May 22, 2018</last_update_posted>
  <responsible_party>
    <name_title>Professor Ip Sau Man Mary</name_title>
    <organization>The University of Hong Kong</organization>
  </responsible_party>
  <keyword>obstructive sleep apnea</keyword>
  <keyword>resistant hypertension</keyword>
  <keyword>refractory hypertension</keyword>
  <keyword>continuous positive airway pressure</keyword>
  <keyword>blood pressure control</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hypertension</mesh_term>
    <mesh_term>Apnea</mesh_term>
    <mesh_term>Sleep Apnea Syndromes</mesh_term>
    <mesh_term>Sleep Apnea, Obstructive</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

